Cargando…

Is homologous recombination really an error-free process?

Homologous recombination (HR) is an evolutionarily conserved process that plays a pivotal role in the equilibrium between genetic stability and diversity. HR is commonly considered to be error-free, but several studies have shown that HR can be error-prone. Here, we discuss the actual accuracy of HR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guirouilh-Barbat, Josée, Lambert, Sarah, Bertrand, Pascale, Lopez, Bernard S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052342/ https://www.ncbi.nlm.nih.gov/pubmed/24966870 http://dx.doi.org/10.3389/fgene.2014.00175

Ejemplares similares

Homologous recombination, cancer and the ‘RAD51 paradox’
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021)

AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers
por: Guirouilh-Barbat, Josée, et al.
Publicado: (2010)

Is Non-Homologous End-Joining Really an Inherently Error-Prone Process?
por: Bétermier, Mireille, et al.
Publicado: (2014)

PARP3 affects the relative contribution of homologous recombination and nonhomologous end-joining pathways
por: Beck, Carole, et al.
Publicado: (2014)

Role of the double-strand break repair pathway in the maintenance of genomic stability
por: Le Guen, Tangui, et al.
Publicado: (2014)

Noncanonical Roles of RAD51
por: Thomas, Mélissa, et al.
Publicado: (2023)

Control of alternative end joining by the chromatin remodeler p400 ATPase
por: Taty-Taty, Gemael-Cedrick, et al.
Publicado: (2016)

WWOX binds MERIT40 and modulates its function in homologous recombination, implications in breast cancer
por: Taouis, Karim, et al.
Publicado: (2023)

53BP1 Protects against CtIP-Dependent Capture of Ectopic Chromosomal Sequences at the Junction of Distant Double-Strand Breaks
por: Guirouilh-Barbat, Josée, et al.
Publicado: (2016)

In vivo reduction of RAD51‐mediated homologous recombination triggers aging but impairs oncogenesis
por: Matos‐Rodrigues, Gabriel, et al.
Publicado: (2023)

PARP2 controls double-strand break repair pathway choice by limiting 53BP1 accumulation at DNA damage sites and promoting end-resection
por: Fouquin, Alexis, et al.
Publicado: (2017)

Recovery of Arrested Replication Forks by Homologous Recombination Is Error-Prone
por: Iraqui, Ismail, et al.
Publicado: (2012)

The extent of error-prone replication restart by homologous recombination is controlled by Exo1 and checkpoint proteins
por: Tsang, Ellen, et al.
Publicado: (2014)

Next-Generation Sequencing Reveals a Very Low Prevalence of Deleterious Mutations of Homologous Recombination Repair Genes and Homologous Recombination Deficiency in Ovarian Clear Cell Carcinoma
por: Liu, Hangqi, et al.
Publicado: (2022)

Combined therapy of colon carcinomas with an oncolytic adenovirus and valproic acid
por: Bressy, Christian, et al.
Publicado: (2017)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
por: Gu, Peng, et al.
Publicado: (2022)

Somatic and germline aberrations in homologous recombination repair genes in Chinese prostate cancer patients
por: Liu, Yixiao, et al.
Publicado: (2023)

The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells
por: De Lorenzo, Silvana B., et al.
Publicado: (2013)

Increased Levels of Genomic Instability and Mutations in Homologous Recombination Genes in Locally Advanced Rectal Carcinomas
por: do Canto, Luisa Matos, et al.
Publicado: (2019)

Reversing Platinum Resistance in High-Grade Serous Ovarian Carcinoma: Targeting BRCA and the Homologous Recombination System
por: Wiedemeyer, W. Ruprecht, et al.
Publicado: (2014)

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
por: Fountzilas, Elena, et al.
Publicado: (2021)

Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma
por: Shang, Xueqian, et al.
Publicado: (2022)

RAD51 protects against nonconservative DNA double-strand break repair through a nonenzymatic function
por: So, Ayeong, et al.
Publicado: (2022)

A Small-Molecule Inhibitor of RAD51 Reduces Homologous Recombination and Sensitizes Multiple Myeloma Cells to Doxorubicin
por: Alagpulinsa, David A., et al.
Publicado: (2014)

Mutation Landscape of Homologous Recombination Repair Genes in Epithelial Ovarian Cancer in China and Its Relationship With Clinicopathlological Characteristics
por: Yao, Qianlan, et al.
Publicado: (2022)

Inferring Homologous Recombination Deficiency of Ovarian Cancer From the Landscape of Copy Number Variation at Subchromosomal and Genetic Resolutions
por: Zhang, Meng, et al.
Publicado: (2021)

Impact of homologous recombination deficiency biomarkers on outcomes in patients with early breast cancer: a systematic review protocol
por: Liao, Hao, et al.
Publicado: (2022)

N(6)-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
por: Navarra, Giovanna, et al.
Publicado: (2020)

Homologous Recombination Is Stimulated by a Decrease in dUTPase in Arabidopsis
por: Dubois, Emeline, et al.
Publicado: (2011)

Homologous Recombination as a Replication Fork Escort: Fork-Protection and Recovery
por: Costes, Audrey, et al.
Publicado: (2012)

Childhood brain tumors: It is the child’s brain that really matters
por: Walker, David A.
Publicado: (2022)

Mouse Models for Deciphering the Impact of Homologous Recombination on Tumorigenesis
por: Matos-Rodrigues, Gabriel, et al.
Publicado: (2021)

Intra-Tumoral CD8+ T-Cell Infiltration and PD-L1 Positivity in Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma
por: Golesworthy, Bryn, et al.
Publicado: (2022)

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status
por: Li, Yongmei, et al.
Publicado: (2022)

MRD in Venetoclax-Based Treatment for AML: Does it Really Matter?
por: Bernardi, Massimo, et al.
Publicado: (2022)

Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
por: Villegas-Pineda, Julio César, et al.
Publicado: (2023)

Platinum-Based Neoadjuvant Chemotherapy Before Radical Prostatectomy for Locally Advanced Prostate Cancer With Homologous Recombination Deficiency: A Case Report
por: Zhuang, Junlong, et al.
Publicado: (2022)

Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors
por: Mekonnen, Negesse, et al.
Publicado: (2022)

Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer
por: Zhang, Linlin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nj89i0p1ici87ba4pg17nrolil